Solasia Pharma K.K. (TYO:4597)

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Business	429.00M	316.00M	617.00M	1.09B	559.00M
Pharmaceutical Business Growth	35.76%	-48.78%	-43.50%	95.35%	23.13%
Total	429.00M	316.00M	617.00M	1.09B	559.00M
Total Growth	35.76%	-48.78%	-43.50%	95.35%	23.13%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Japan	133.00M	129.00M	81.00M	323.00M	243.00M
Japan Growth	3.10%	59.26%	-74.92%	32.92%	417.02%
China and Others	295.00M	187.00M	536.00M	768.00M	315.00M
China and Others Growth	57.75%	-65.11%	-30.21%	143.81%	-22.41%
Total	428.00M	316.00M	617.00M	1.09B	558.00M
Total Growth	35.44%	-48.78%	-43.45%	95.52%	23.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 21, 2026

Data Sources Report a data error